Search - Prime Therapeutics

366 Results for GLP-1 Pipeline Update

BioSpace: GLP-1 Side Effects Only One Factor Driving Patient Discontinuation Rates

BioSpace: While drug developers work to mitigate the side effects associated with GLP-1–based obesity drugs, recent studies reveal that myriad variables are causing patients to stop treatment

PA Sub-Categories: GLP-1 Prime Article: In the News
Prime continues to lead industry on GLP-1 research: 1 in 7 stays on GLP-1 drugs for weight loss after two years

Real-world, integrated data follows-up on previous insights, analytics.

PA Sub-Categories: GLP-1 Prime Article: Press Releases
GLP-1 Strategy

Develop a holistic GLP-1 strategy An evidence-based approach to GLP-1 drugs helps you implement custom strategies that promote clinically appropriate use and consider affordability, long-term value...
Counterfeit GLP-1s: What to watch out for

Jessica Johnson, clinical consultant, shares how the Special Investigations Unit at Prime helps identify cases of fraud

PA Sub-Categories: GLP-1 Prime Article: Perspectives